Wednesday, September 27, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



New Russian anti-Covid-19 vaccine candidate shows efficacy

Moscow, Sep 30 (Prensa Latina) Veronika Skvortsova, director of the Federal Medical-Biological Agency (FMBA), said that Russia's new Covid-19 vaccine candidate has proven efficacy and safety in preclinical trials.

She explained that the vaccine candidate has been developed for more than a year and it now goes through the first and second phases of combined clinical trials, TASS news agency reported.

Skvortsova stated that the vaccine candidate will be used to fight all SARS-CoV-2 strains because ‘its effectiveness does not depend on the transformations and mutations occurring in the spike protein on the surface of the virus.’

The FMBA head stressed that the new vaccine candidate will generate cell-mediated immunity, but also humoral immunity.

‘This has already been confirmed in preclinical trials and now in clinical trials,’ she concluded.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.